A detailed history of Arlington Trust CO LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Arlington Trust CO LLC holds 1,118 shares of NVO stock, worth $120,330. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,118
Previous 1,118 -0.0%
Holding current value
$120,330
Previous $159,000 16.35%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$87.78 - $105.45 $2.65 Million - $3.19 Million
-30,234 Reduced 96.43%
1,118 $115,000
Q3 2023

Oct 24, 2023

BUY
$90.94 - $199.54 $2.85 Million - $6.26 Million
31,352 New
31,352 $2.85 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Arlington Trust CO LLC Portfolio

Follow Arlington Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Trust CO LLC with notifications on news.